PENANG, June 2 (Bernama) — B. Braun, one of the largest medical technology companies in the world, headquartered in Germany, announced the expansion of its portfolio of testing capabilities for healthcare solutions related to intravenous access, surgical technologies, intravenous systems, central venous puncture and pain control; in Penang.
Prior to the expansion, the Global Test Centre based in Penang had only supported 200,000 scientific measurements per annum for medical devices related to intravenous access and drug delivery systems. Due to the proven competencies, strong product knowledge and efficiency displayed by the local team of Malaysian engineers, the volume of product testing has been tripled to more than 600,000 scientific measurements per annum. Furthermore, medical devices for infusion systems, central venous puncture and pain control, which are being manufactured in Germany, have also been added to the portfolio being tested in Penang.